Results 111 to 120 of about 25,773 (228)

The importance of the serum quantitative levels of hepatitis B surface antigen and hepatitis B e antigen in children with chronic hepatitis B

open access: yesThe Turkish Journal of Gastroenterology, 2015
Background/Aims: We aimed to investigate the clinical importance of quantitative levels of serum hepatitis B surface antigen (HBsAg) and hepatitis B e antigen (HBeAg), and to detect their correlation with hepatitis B virus (HBV) DNA load, alanine ...
Kaan Demirören   +2 more
doaj   +1 more source

HBeAg-induced miR-106b promotes cell growth by targeting the retinoblastoma gene

open access: yes, 2017
Chronic HBV infection is a major cause of hepatocellular carcinoma (HCC). The association between hepatitis B “e” antigen (HBeAg) and HCC is well-established by epidemiological studies.
Manish Kandpal   +2 more
core   +1 more source

Seroepidemiology of hepatitis B virus (HBV) and relationship to serum transaminase levels in Indian population

open access: yesJournal of Family Medicine and Primary Care
Background: Hepatitis B virus (HBV) infection is a serious public health issue that must be addressed. Aim: The goal of this study was to investigate the correlation between serological status for hepatitis Be antigen (HBeAg)/anti-HBe, serum transaminase
Manoj Kumar   +6 more
doaj   +1 more source

Necroinflammation grade and fibrosis stage in HBeAg-negative patients.

open access: yes, 2013
(A) Necroinflammation grade in HBeAg-negative patients. Significant necroinflammation (≥A2) was found 9.1%, 17.8% and 57.6% in PNALT, ALT 1-2×ULN and >2×ULN group, respectively. (B) Fibrosis stage in HBeAg-positive patients. Significant fibrosis (≥F2) was
Zhanhui Wang (160469)   +9 more
core   +1 more source

What should be the endpoints of oral therapy in HBeAg-positive versus HBeAg-negative patients with chronic hepatitis B

open access: yes, 2012
Therapy with currently available oral nucleos(t) ide analogs (NA) in patients with chronic hepatitis B (CHB, HBeAg-positive or -negative) should ultimately aim at preventing progression to cirrhosis and hepatocellular carcinoma.
Hadziyannis, S.J., Vassilopoulos, D.
core   +1 more source

De novo combination therapy adefovir plus lamivudine as a treatment for women of child-bearing age with HBeAg-positive chronic hepatitis B before pregnancy

open access: yes, 2014
Substantial progress has been achieved in antiviral therapy for chronic hepatitis B; however, options for women of child-bearing age with HBeAg-positive chronic hepatitis B remain a challenge.
Liu, Shuai-Wei   +5 more
core   +1 more source

Distribution of different responders in mothers with different HBeAg status.

open access: yes, 2013
Abbreviations: HBeAg, hepatitis B e antigen.
Yu Chen (29959)   +3 more
core   +1 more source

Indeterminate-Grey Zone of HBeAg-Negative Chronic Hepatitis B Is Associated with a Higher Risk of Hepatocellular Carcinoma Compared to HBeAg-Negative Chronic Infection—A Systematic Review and Meta-Analysis

open access: yesLivers
Background and Aim: The management of patients with chronic Hepatitis B Virus (HBV) HBeAg-negative infection in the indeterminate-grey zone (GZ) remains debatable.
Rodanthi Syrigou   +4 more
doaj   +1 more source

Response rates in HBeAg-positive and -negative patients.

open access: yes, 2015
Response rates in HBeAg-positive and -negative patients.
Jee-Fu Huang (292609)   +10 more
core   +1 more source

Serum hepatitis B core antibody levels predict HBeAg seroconversion in chronic hepatitis B patients with high viral load treated with nucleos(t)ide analogs

open access: yes, 2018
 Shaohang Cai,* Zhandong Li,* Tao Yu, Muye Xia, Jie Peng Department of Infectious Diseases and Hepatology Unit, NanFang Hospital, Southern Medical University, Guangzhou, Guangdong Province, China *These authors contributed equally to this ...
Cai S, Li Z, Xia M, Yu T, Peng J
core  

Home - About - Disclaimer - Privacy